The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1515
February 27, 2017
View Complete Issue         Table of Contents 2019 
Auvi-Q Epinephrine Auto-Injector Returns
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Auvi-Q Epinephrine Auto-Injector Returns
February 27, 2017 (Issue: 1515)
Auvi-Q (Kaléo; previously manufactured and marketed by Sanofi), the epinephrine auto-injector approved by the FDA in 2012 for emergency treatment of anaphylaxis and voluntarily withdrawn in 2015 due to potential inaccurate dosage delivery,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Auvi-Q Epinephrine Auto-Injector Returns
Article code: 1515a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.